DD298412A5 - Verfahren zur herstellung von polypeptiden, die geeignet sind als antagonisten exzitatorischer aminosaeure-neurotransmitter und/oder blocker der calciumkanaele - Google Patents

Verfahren zur herstellung von polypeptiden, die geeignet sind als antagonisten exzitatorischer aminosaeure-neurotransmitter und/oder blocker der calciumkanaele Download PDF

Info

Publication number
DD298412A5
DD298412A5 DD89343270A DD34327089A DD298412A5 DD 298412 A5 DD298412 A5 DD 298412A5 DD 89343270 A DD89343270 A DD 89343270A DD 34327089 A DD34327089 A DD 34327089A DD 298412 A5 DD298412 A5 DD 298412A5
Authority
DD
German Democratic Republic
Prior art keywords
minutes
cys
acetonitrile
lys
gly
Prior art date
Application number
DD89343270A
Other languages
German (de)
English (en)
Inventor
Nicholas A Saccomano
Robert A Volkmann
Original Assignee
������@���Kk��
����������@������@�������k���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk��, ����������@������@�������k���Kk�� filed Critical ������@���Kk��
Publication of DD298412A5 publication Critical patent/DD298412A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/16—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Insects & Arthropods (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
DD89343270A 1989-04-28 1989-04-27 Verfahren zur herstellung von polypeptiden, die geeignet sind als antagonisten exzitatorischer aminosaeure-neurotransmitter und/oder blocker der calciumkanaele DD298412A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34618189A 1989-04-28 1989-04-28

Publications (1)

Publication Number Publication Date
DD298412A5 true DD298412A5 (de) 1992-02-20

Family

ID=23358305

Family Applications (2)

Application Number Title Priority Date Filing Date
DD89343270A DD298412A5 (de) 1989-04-28 1989-04-27 Verfahren zur herstellung von polypeptiden, die geeignet sind als antagonisten exzitatorischer aminosaeure-neurotransmitter und/oder blocker der calciumkanaele
DD90340246A DD293959A5 (de) 1989-04-28 1990-04-27 Verfahren zur herstellung von polyaminen und polypeptiden, die geeignet sind als antagonisten exzitatorischer aminosaeure-neurotransmitter und/oder blocker der calciumkanaele

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD90340246A DD293959A5 (de) 1989-04-28 1990-04-27 Verfahren zur herstellung von polyaminen und polypeptiden, die geeignet sind als antagonisten exzitatorischer aminosaeure-neurotransmitter und/oder blocker der calciumkanaele

Country Status (25)

Country Link
EP (2) EP0395357B1 (zh)
JP (8) JPH0774187B2 (zh)
KR (2) KR920007554B1 (zh)
CN (2) CN1038931C (zh)
AT (1) ATE131813T1 (zh)
AU (1) AU615144B2 (zh)
CA (2) CA2194103C (zh)
CZ (1) CZ283830B6 (zh)
DD (2) DD298412A5 (zh)
DE (1) DE69024253T2 (zh)
DK (1) DK0395357T3 (zh)
EG (1) EG19311A (zh)
ES (1) ES2081929T3 (zh)
FI (1) FI902139A0 (zh)
GR (1) GR3018976T3 (zh)
HU (1) HU223593B1 (zh)
IE (2) IE69848B1 (zh)
IL (3) IL94147A (zh)
NO (1) NO300128B1 (zh)
NZ (2) NZ244480A (zh)
PL (1) PL165148B1 (zh)
PT (1) PT93876B (zh)
RU (1) RU2037498C1 (zh)
YU (1) YU84590A (zh)
ZA (1) ZA903229B (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122596A (en) * 1989-09-29 1992-06-16 Pfizer Inc. Polypeptides useful as blockers of calcium channels
US5037846A (en) * 1990-01-02 1991-08-06 Pfizer Inc. Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters
US5312928A (en) * 1991-02-11 1994-05-17 Cambridge Neuroscience Calcium channel antagonists and methodology for their identification
US5461032A (en) * 1991-03-01 1995-10-24 Fmc Corporation Insecticidally effective peptides
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
WO1993004373A1 (en) * 1991-08-23 1993-03-04 Nps Pharmaceuticals, Inc. Calcium receptor active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5185369A (en) * 1991-08-23 1993-02-09 Pfizer Inc. Synthetic heteroaryl polyamines as excitatory amino acid neurotransmitter antagonists
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
IL104419A0 (en) * 1992-01-24 1993-05-13 Fmc Corp Insecticidally effective peptides
US5763568A (en) * 1992-01-31 1998-06-09 Zeneca Limited Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
KR100296899B1 (ko) * 1993-02-23 2001-10-24 쉘비 칼베르그 모르스 칼슘수용체활성분자
US5457178A (en) * 1993-07-07 1995-10-10 Fmc Corporation Insecticidally effective spider toxin
EP0729359A4 (en) * 1993-11-15 1999-06-02 Baker Med Res Inst METHOD FOR TREATING CARDIAC DYSFUNCTION AND PHARMACEUTICAL COMPOSITIONS FOR USE THEREFOR
BRPI9509411B8 (pt) 1994-10-21 2021-07-06 Nps Pharma Inc composto modulador de receptor de íon inorgânico e composição farmacêutica
US5756459A (en) * 1995-06-07 1998-05-26 Fmc Corporation Insecticidally effective peptides isolatable from phidippus spider venom
ES2201300T3 (es) * 1996-05-01 2004-03-16 Nps Pharmaceuticals, Inc. Compuestos activos frente a receptores de iones inorganicos.
AUPO733397A0 (en) * 1997-06-13 1997-07-10 University Of Sydney, The Pesticidal compounds
CN1071115C (zh) * 1998-08-07 2001-09-19 彭小平 一种治疗胃肠炎及溃疡的复方药
FR2802817B1 (fr) * 1999-12-23 2002-10-11 Centre Nat Rech Scient Nouveaux inhibiteurs de glycosidases et leurs applications pharmacologiques, notamment pour traiter le diabete
WO2001070773A2 (en) * 2000-03-22 2001-09-27 Basf Ag Insecticidal peptides and methods for using same
FR2820136A1 (fr) * 2001-01-26 2002-08-02 Aventis Pharma Sa Nouveaux derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
FR2885129B1 (fr) 2005-04-29 2007-06-15 Proskelia Sas Nouveaux derives de l'ureee substituee parun thiazole ou benzothiazole, leur procede de preparation, leur application a titre de medicaments, les compositions pharmaceutiques les renfermant et utilisation.
CN108949771B (zh) * 2018-08-02 2021-10-19 南京农业大学 拟环纹豹蛛c家族杀虫基因及其编码的成熟肽与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950739A (en) * 1988-02-10 1990-08-21 New York University Membrane calcium channels and factors and methods for blocking, isolating and purifying calcium channels
GB8820442D0 (en) * 1988-08-30 1988-09-28 Usherwood P N R Therapeutic polyamine amides

Also Published As

Publication number Publication date
CZ283830B6 (cs) 1998-06-17
RU2037498C1 (ru) 1995-06-19
HUT55415A (en) 1991-05-28
IE69848B1 (en) 1996-10-02
EP0696578A2 (en) 1996-02-14
IL94147A (en) 1998-10-30
EP0696578A3 (en) 1998-04-29
JPH09132596A (ja) 1997-05-20
JP2746359B2 (ja) 1998-05-06
IE950345L (en) 1990-10-28
HU902610D0 (en) 1990-09-28
EG19311A (en) 1995-02-28
DK0395357T3 (da) 1996-01-29
AU5453590A (en) 1990-11-08
JPH09118690A (ja) 1997-05-06
EP0395357A3 (en) 1992-04-01
JPH09118693A (ja) 1997-05-06
KR920007554B1 (ko) 1992-09-07
DE69024253T2 (de) 1996-05-15
GR3018976T3 (en) 1996-05-31
EP0395357B1 (en) 1995-12-20
JP2746361B2 (ja) 1998-05-06
JPH07165793A (ja) 1995-06-27
JP2744904B2 (ja) 1998-04-28
IL94147A0 (en) 1991-01-31
JPH0314551A (ja) 1991-01-23
NZ233469A (zh) 1994-12-22
IL112522A (en) 2005-12-18
ES2081929T3 (es) 1996-03-16
DD293959A5 (de) 1991-09-19
NO300128B1 (no) 1997-04-14
KR930000163B1 (ko) 1993-01-11
CN1038931C (zh) 1998-07-01
PL165148B1 (en) 1994-11-30
JP2691141B2 (ja) 1997-12-17
JP2746360B2 (ja) 1998-05-06
JP2747279B2 (ja) 1998-05-06
HU223593B1 (hu) 2004-09-28
CA2194103C (en) 2000-01-04
IL112522A0 (en) 1995-05-26
NO901881D0 (no) 1990-04-27
PT93876B (pt) 1996-09-30
DE69024253D1 (de) 1996-02-01
EP0395357A2 (en) 1990-10-31
PT93876A (pt) 1990-11-20
JPH09118692A (ja) 1997-05-06
JPH09118691A (ja) 1997-05-06
CA2015505A1 (en) 1990-10-28
FI902139A0 (fi) 1990-04-27
ZA903229B (en) 1991-12-24
JPH0774187B2 (ja) 1995-08-09
IE901496L (en) 1990-10-28
KR900015745A (ko) 1990-11-10
YU84590A (sh) 1992-09-07
JPH09118694A (ja) 1997-05-06
ATE131813T1 (de) 1996-01-15
AU615144B2 (en) 1991-09-19
CA2194103A1 (en) 1990-10-29
CN1047078A (zh) 1990-11-21
CA2015505C (en) 1997-03-11
NZ244480A (zh) 1994-12-22
NO901881L (no) 1990-10-29
CS215790A3 (en) 1992-02-19
CN1136960A (zh) 1996-12-04

Similar Documents

Publication Publication Date Title
DD298412A5 (de) Verfahren zur herstellung von polypeptiden, die geeignet sind als antagonisten exzitatorischer aminosaeure-neurotransmitter und/oder blocker der calciumkanaele
DE60102899T2 (de) Verfahren zur lösung von glucagon-ähnlichen peptid-1 (glp-1) verbindungen
EP0167575B1 (de) Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung
DE69108830T2 (de) Neue im schwein vorkommende physiologisch aktive peptide.
DE69731097T2 (de) Conotoxin Peptide PVIIA
DE60003837T2 (de) Tetrapeptid, das die funktionelle aktivität von neuronen stimuliert, dieses enthaltendes pharmakologisches mittel und seine verwendung
DE69007739T2 (de) Polypeptide verwertbar als Kalziumkanälen-Blocker.
WO2006042745A2 (de) Chemisch modifizierte iapp - peptidanaloga
DE69734885T2 (de) Klasse e-spannungsabhängiger calciumkanal-antagonist und verfahren
DE60112424T2 (de) Protonen-abhängiges na+-kanal hemmendes polypeptid
DE69312320T2 (de) Den kalzium kanal blokierende polypeptide aus filistata hibernalis.
EP1023445B1 (de) Cadherin derived growth factor und seine verwendung
DE69202136T2 (de) Neuartiges calcitonin, und seine herstellung und verwendung.
DE60122301T2 (de) Kaliumkanalprotein kcnq5, ein ziel für erkrankungen des zentralen nervensystems und herz-gefäss-systems
DE69907239T2 (de) Rho-conotoxin Peptide mit selektiver antagonistischer Aktivität auf den alpha-1-adrenozeptor
EP1267916A2 (de) Arzneimittel enthaltend tissue inhibitor of metalloproteinases-2 (timp-2) als osteoanabol wirksame substanz
WO2001060844A2 (de) Peptid und dafür kodierende nukleinsäure zur bestimmung, diagnostik und therapie von erkrankungen des nervensystems
EP0133308A2 (de) Appetitregulierender Wirkstoff und Verfahren zur Herstellung desselben
DE1817960B2 (de) Cyclopeptid und seine herstellung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee